CLASS I Drug recall · Reported 23 May 2018 · FDA Enforcement Report

Piperacillin and Tazobactam for Injection, USP per vial recalled

AuroMedics Pharma is recalling Piperacillin and Tazobactam for Injection, USP per vial, For Intravenous Use Only, distributed nationwide in the US. The recall was initiated on 1 May 2018 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #s: PP0317061-A, PP0317049-A; EXP August 2019
NDC55150-119, 55150-120, 55150-121
UPC0355150119301, 0355150120307, 0355150121502
Quantity recalled77,400 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0926-2018
FDA event ID
79995
Recalling firm
AuroMedics Pharma, East Windsor, NJ
Manufacturer
Eugia US LLC
Classification
Class I
Status
Terminated
Recall initiated
1 May 2018
FDA classified
17 Jul 2018
Reported
23 May 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter
Drug class
Antibiotics

Timeline

1 May 2018Recall initiated by company
23 May 2018Published in enforcement report+22 days
17 Jul 2018Classified by FDA+55 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass

Product as listed by the FDA

Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx Only, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ 05610. NDC 55150-120-30

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass

Which lots are affected?

Lot #s: PP0317061-A, PP0317049-A; EXP August 2019

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from AuroMedics Pharma

All 36

Other Piperacillin recalls

All 17